FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071490259> ?p ?o ?g. }

• W2071490259 endingPage "S16" @default.
• W2071490259 startingPage "S16" @default.
• W2071490259 abstract "ObjectiveTo evaluate the success rate of proximal tubal occlusion with placement of Essure® micro-inserts in women with hydrosalpinx (HS) prior to undergoing in vitro fertilization (IVF), and to observe pregnancy rates post-IVF.DesignProspective, non-randomized, off-label, observational study of micro-insert tubal occlusion in women with HS and subsequent pregnancy rates following IVF using fresh or frozen embryos.Materials and methodsPlacement of Essure micro-inserts followed by a hysterosalpingogram (HSG) 3 months post-procedure, and IVF in 7 women ages 32–44 presenting with infertility and unilateral or bilateral HS as determined by laparoscopy or HSG.ResultsBilateral micro-insert placement was performed in 5 women, unilateral in 1 woman (with a unilateral HS), and 1 unsuccessful placement attempt. The devices were intentionally placed with an average of 2–3 trailing coils visible post-procedure. Follow-up HSG has been completed in 4 patients, with all demonstrating tubal occlusion. One woman elected to not have an HSG, and 1 patient is awaiting her HSG. IVF treatment was initiated in all patients an average of 3.5 months post-confirmation of tubal occlusion. Three women became pregnant on their first IVF cycle with term deliveries, one is currently 3 months pregnant from a frozen embryo cycle, one did not achieve pregnancy and one is awaiting her follow-up HSG prior to beginning IVF. There have been no complications from Essure placement or from the devices remaining in place during pregnancy.ConclusionsPreliminary results demonstrate an excellent pregnancy rate with IVF following Essure micro-insert placement for HS. ObjectiveTo evaluate the success rate of proximal tubal occlusion with placement of Essure® micro-inserts in women with hydrosalpinx (HS) prior to undergoing in vitro fertilization (IVF), and to observe pregnancy rates post-IVF. To evaluate the success rate of proximal tubal occlusion with placement of Essure® micro-inserts in women with hydrosalpinx (HS) prior to undergoing in vitro fertilization (IVF), and to observe pregnancy rates post-IVF. DesignProspective, non-randomized, off-label, observational study of micro-insert tubal occlusion in women with HS and subsequent pregnancy rates following IVF using fresh or frozen embryos. Prospective, non-randomized, off-label, observational study of micro-insert tubal occlusion in women with HS and subsequent pregnancy rates following IVF using fresh or frozen embryos. Materials and methodsPlacement of Essure micro-inserts followed by a hysterosalpingogram (HSG) 3 months post-procedure, and IVF in 7 women ages 32–44 presenting with infertility and unilateral or bilateral HS as determined by laparoscopy or HSG. Placement of Essure micro-inserts followed by a hysterosalpingogram (HSG) 3 months post-procedure, and IVF in 7 women ages 32–44 presenting with infertility and unilateral or bilateral HS as determined by laparoscopy or HSG. ResultsBilateral micro-insert placement was performed in 5 women, unilateral in 1 woman (with a unilateral HS), and 1 unsuccessful placement attempt. The devices were intentionally placed with an average of 2–3 trailing coils visible post-procedure. Follow-up HSG has been completed in 4 patients, with all demonstrating tubal occlusion. One woman elected to not have an HSG, and 1 patient is awaiting her HSG. IVF treatment was initiated in all patients an average of 3.5 months post-confirmation of tubal occlusion. Three women became pregnant on their first IVF cycle with term deliveries, one is currently 3 months pregnant from a frozen embryo cycle, one did not achieve pregnancy and one is awaiting her follow-up HSG prior to beginning IVF. There have been no complications from Essure placement or from the devices remaining in place during pregnancy. Bilateral micro-insert placement was performed in 5 women, unilateral in 1 woman (with a unilateral HS), and 1 unsuccessful placement attempt. The devices were intentionally placed with an average of 2–3 trailing coils visible post-procedure. Follow-up HSG has been completed in 4 patients, with all demonstrating tubal occlusion. One woman elected to not have an HSG, and 1 patient is awaiting her HSG. IVF treatment was initiated in all patients an average of 3.5 months post-confirmation of tubal occlusion. Three women became pregnant on their first IVF cycle with term deliveries, one is currently 3 months pregnant from a frozen embryo cycle, one did not achieve pregnancy and one is awaiting her follow-up HSG prior to beginning IVF. There have been no complications from Essure placement or from the devices remaining in place during pregnancy. ConclusionsPreliminary results demonstrate an excellent pregnancy rate with IVF following Essure micro-insert placement for HS. Preliminary results demonstrate an excellent pregnancy rate with IVF following Essure micro-insert placement for HS." @default.
• W2071490259 created "2016-06-24" @default.
• W2071490259 creator A5060916920 @default.
• W2071490259 date "2007-09-01" @default.
• W2071490259 modified "2023-09-25" @default.
• W2071490259 title "Utilization of the Essure® micro-insert for the treatment of hydrosalpinx prior to in vitro fertilization" @default.
• W2071490259 doi "https://doi.org/10.1016/j.fertnstert.2007.07.071" @default.
• W2071490259 hasPublicationYear "2007" @default.
• W2071490259 type Work @default.
• W2071490259 sameAs 2071490259 @default.
• W2071490259 citedByCount "20" @default.
• W2071490259 countsByYear W20714902592012 @default.
• W2071490259 countsByYear W20714902592013 @default.
• W2071490259 countsByYear W20714902592014 @default.
• W2071490259 countsByYear W20714902592015 @default.
• W2071490259 countsByYear W20714902592016 @default.
• W2071490259 countsByYear W20714902592017 @default.
• W2071490259 countsByYear W20714902592021 @default.
• W2071490259 crossrefType "journal-article" @default.
• W2071490259 hasAuthorship W2071490259A5060916920 @default.
• W2071490259 hasBestOaLocation W20714902591 @default.
• W2071490259 hasConcept C131872663 @default.
• W2071490259 hasConcept C160099875 @default.
• W2071490259 hasConcept C2776537878 @default.
• W2071490259 hasConcept C2776625026 @default.
• W2071490259 hasConcept C2777688143 @default.
• W2071490259 hasConcept C2779076696 @default.
• W2071490259 hasConcept C2779234561 @default.
• W2071490259 hasConcept C2779492760 @default.
• W2071490259 hasConcept C2779619083 @default.
• W2071490259 hasConcept C2908647359 @default.
• W2071490259 hasConcept C29456083 @default.
• W2071490259 hasConcept C2986817661 @default.
• W2071490259 hasConcept C512716672 @default.
• W2071490259 hasConcept C54355233 @default.
• W2071490259 hasConcept C71924100 @default.
• W2071490259 hasConcept C86803240 @default.
• W2071490259 hasConcept C99454951 @default.
• W2071490259 hasConceptScore W2071490259C131872663 @default.
• W2071490259 hasConceptScore W2071490259C160099875 @default.
• W2071490259 hasConceptScore W2071490259C2776537878 @default.
• W2071490259 hasConceptScore W2071490259C2776625026 @default.
• W2071490259 hasConceptScore W2071490259C2777688143 @default.
• W2071490259 hasConceptScore W2071490259C2779076696 @default.
• W2071490259 hasConceptScore W2071490259C2779234561 @default.
• W2071490259 hasConceptScore W2071490259C2779492760 @default.
• W2071490259 hasConceptScore W2071490259C2779619083 @default.
• W2071490259 hasConceptScore W2071490259C2908647359 @default.
• W2071490259 hasConceptScore W2071490259C29456083 @default.
• W2071490259 hasConceptScore W2071490259C2986817661 @default.
• W2071490259 hasConceptScore W2071490259C512716672 @default.
• W2071490259 hasConceptScore W2071490259C54355233 @default.
• W2071490259 hasConceptScore W2071490259C71924100 @default.
• W2071490259 hasConceptScore W2071490259C86803240 @default.
• W2071490259 hasConceptScore W2071490259C99454951 @default.
• W2071490259 hasLocation W20714902591 @default.
• W2071490259 hasOpenAccess W2071490259 @default.
• W2071490259 hasPrimaryLocation W20714902591 @default.
• W2071490259 hasRelatedWork W2024455103 @default.
• W2071490259 hasRelatedWork W2071490259 @default.
• W2071490259 hasRelatedWork W2103956589 @default.
• W2071490259 hasRelatedWork W2123923037 @default.
• W2071490259 hasRelatedWork W2276863329 @default.
• W2071490259 hasRelatedWork W2407804577 @default.
• W2071490259 hasRelatedWork W2621449612 @default.
• W2071490259 hasRelatedWork W2959681283 @default.
• W2071490259 hasRelatedWork W4255981567 @default.
• W2071490259 hasRelatedWork W97169410 @default.
• W2071490259 hasVolume "88" @default.
• W2071490259 isParatext "false" @default.
• W2071490259 isRetracted "false" @default.
• W2071490259 magId "2071490259" @default.
• W2071490259 workType "article" @default.